Solomon Systech International (2878) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
8 Oct, 2026Executive summary
H1 2025 revenue fell 25.8% YoY to US$45.9m, mainly from lower shipment volume and average selling prices amid delayed next-generation launches and competitive pricing pressure.
Profit attributable to owners declined to US$4.0m from US$7.5m; gross margin rose to 39.6% from 32.0%, supported by cost controls and product-mix optimisation.
Financial highlights
Gross profit was US$18.2m versus US$19.8m; revenue was US$45.934m versus US$61.915m for H1 2024.
Profit before tax was US$4.104m versus US$7.557m; profit attributable to owners was US$4.003m versus US$7.471m.
Basic and diluted EPS were US$0.16 each, down from US$0.30 each in H1 2024.
R&D costs increased 24.3% YoY to US$9.9m, or 21.6% of revenue versus 12.9%; administrative expenses rose 5.8% to US$5.2m.
Outlook and guidance
H2 demand may soften after H1 retailer stockpiling; related US sales are expected to adjust, while uncertain US trade policy and tariffs weigh on the outlook.
Strategy prioritises accelerating product commercialisation, increasing R&D investment, broadening market reach and adjusting the product portfolio to market shifts.
Spectra 6 large e-paper signage and learning-board driver ICs are expected to enter mass production in H2; seven-colour label prototypes are planned for Q4.
Automotive display ICs are expected to launch in H2 2025; mini-LED backlight standard ICs are also targeted for H2, including automotive HUD applications.
Latest events from Solomon Systech International
- Lower sales and profit met by stronger large-display demand and investment in new applications.2878
H1 2024 - Higher gross margin and large-display growth softened a sharp FY2024 revenue decline.2878
H2 2024 - Higher shipments and margin could not offset FY2025 pricing pressure; 2026 growth hinges on e-paper and auto launches.2878
H2 2025 - Cost inflation drove an H1 loss as new-product ramps offered a path to gradual recovery.2878
H1 2026